Back to mobile site

Theragenics Corp. (TGX) Signs with Core Oncology to Distribute TheraSeed Palladium-103 in Canada and U.S.

January 12, 2010 7:47 AM EST Send to a Friend
Theragenics Corporation (NYSE: TGX) today announced that it has signed an agreement with Core Oncology, Inc. for the distribution of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login